Analysis of Long-term (Investment) Activity Ratios
Quarterly Data
Activity ratios measure how efficiently a company performs day-to-day tasks, such us the collection of receivables and management of inventory.
Long-term Activity Ratios (Summary)
Thermo Fisher Scientific Inc., long-term (investment) activity ratios (quarterly data)
Based on: 10-K (filing date: 2021-02-25), 10-Q (filing date: 2020-10-30), 10-Q (filing date: 2020-07-31), 10-Q (filing date: 2020-05-01), 10-K (filing date: 2020-02-26), 10-Q (filing date: 2019-11-01), 10-Q (filing date: 2019-08-02), 10-Q (filing date: 2019-05-03), 10-K (filing date: 2019-02-27), 10-Q (filing date: 2018-11-02), 10-Q (filing date: 2018-08-03), 10-Q (filing date: 2018-05-04), 10-K (filing date: 2018-02-28), 10-Q (filing date: 2017-11-03), 10-Q (filing date: 2017-08-04), 10-Q (filing date: 2017-05-05), 10-K (filing date: 2017-02-28), 10-Q (filing date: 2016-11-04), 10-Q (filing date: 2016-08-05), 10-Q (filing date: 2016-05-06).
Long-term activity ratio | Description | The company |
---|---|---|
Net fixed asset turnover | An activity ratio calculated as total revenue divided by net fixed assets. | Thermo Fisher Scientific Inc.’s net fixed asset turnover ratio improved from Q2 2020 to Q3 2020 but then slightly deteriorated from Q3 2020 to Q4 2020. |
Total asset turnover | An activity ratio calculated as total revenue divided by total assets. | Thermo Fisher Scientific Inc.’s total asset turnover ratio improved from Q2 2020 to Q3 2020 and from Q3 2020 to Q4 2020. |
Equity turnover | An activity ratio calculated as total revenue divided by shareholders’ equity. | Thermo Fisher Scientific Inc.’s equity turnover ratio improved from Q2 2020 to Q3 2020 and from Q3 2020 to Q4 2020. |
Net Fixed Asset Turnover
Thermo Fisher Scientific Inc., net fixed asset turnover calculation (quarterly data)
Dec 31, 2020 | Sep 26, 2020 | Jun 27, 2020 | Mar 28, 2020 | Dec 31, 2019 | Sep 28, 2019 | Jun 29, 2019 | Mar 30, 2019 | Dec 31, 2018 | Sep 29, 2018 | Jun 30, 2018 | Mar 31, 2018 | Dec 31, 2017 | Sep 30, 2017 | Jul 1, 2017 | Apr 1, 2017 | Dec 31, 2016 | Oct 1, 2016 | Jul 2, 2016 | Apr 2, 2016 | |||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Selected Financial Data (US$ in millions) | ||||||||||||||||||||||||||
Revenues | 10,550 | 8,521 | 6,917 | 6,230 | 6,829 | 6,272 | 6,316 | 6,125 | 6,507 | 5,920 | 6,078 | 5,853 | 6,047 | 5,116 | 4,990 | 4,765 | 4,953 | 4,491 | 4,535 | 4,295 | ||||||
Property, plant and equipment, net | 5,912 | 5,180 | 4,887 | 4,736 | 4,749 | 4,420 | 4,394 | 4,192 | 4,165 | 3,978 | 3,952 | 4,059 | 4,047 | 3,932 | 2,600 | 2,563 | 2,578 | 2,599 | 2,452 | 2,483 | ||||||
Long-term Activity Ratio | ||||||||||||||||||||||||||
Net fixed asset turnover1 | 5.45 | 5.50 | 5.37 | 5.42 | 5.38 | 5.71 | 5.66 | 5.88 | 5.85 | 6.01 | 5.84 | 5.42 | 5.17 | 5.04 | 7.39 | 7.31 | 7.09 | — | — | — | ||||||
Benchmarks | ||||||||||||||||||||||||||
Net Fixed Asset Turnover, Competitors2 | ||||||||||||||||||||||||||
Becton, Dickinson & Co. | 2.89 | 2.90 | 3.07 | 3.00 | 3.06 | 3.08 | 3.11 | 3.18 | 2.97 | 2.77 | 2.50 | 2.33 | 2.61 | 2.76 | 3.13 | 3.25 | 3.20 | 3.23 | 3.24 | 2.83 | ||||||
Boston Scientific Corp. | 4.76 | 4.90 | 4.89 | 5.14 | 5.16 | 5.35 | 5.54 | 5.58 | 5.51 | 5.59 | 5.54 | 5.45 | 5.33 | 5.26 | 5.28 | 5.19 | 5.14 | — | — | — | ||||||
Danaher Corp. | 6.83 | 6.68 | 6.35 | 6.03 | 7.78 | 7.31 | 7.43 | 7.75 | 7.92 | 7.97 | 7.74 | 7.60 | 7.47 | 7.35 | 7.20 | 7.13 | 7.17 | — | — | — | ||||||
Edwards Lifesciences Corp. | 3.14 | 3.42 | 3.61 | 4.07 | 4.10 | 4.26 | 4.26 | 4.28 | 4.29 | 4.40 | 4.61 | 4.84 | 5.05 | 5.10 | 5.15 | 5.35 | 5.11 | — | — | — | ||||||
Intuitive Surgical Inc. | 2.76 | 2.85 | 3.00 | 3.36 | 3.52 | 3.74 | 3.91 | 4.12 | 4.59 | 4.78 | 5.02 | 4.99 | 5.10 | 5.12 | 5.31 | 5.60 | 5.90 | — | — | — | ||||||
Medtronic PLC | 5.99 | 6.52 | 6.50 | 6.51 | 6.54 | 6.65 | 6.70 | 6.62 | 6.51 | 6.58 | 6.67 | 6.82 | 6.81 | 5.94 | 5.93 | 5.97 | 5.96 | 6.16 | 5.55 | 4.98 | ||||||
Stryker Corp. | 5.21 | 5.62 | 5.57 | 5.74 | 5.80 | 5.91 | 5.95 | 6.04 | 5.94 | 6.10 | 6.21 | 6.20 | 6.30 | 6.55 | 6.80 | 7.12 | 7.22 | — | — | — | ||||||
UnitedHealth Group Inc. | 29.64 | 30.80 | 30.30 | 29.91 | 27.60 | 27.98 | 26.97 | 27.93 | 26.59 | 27.18 | 26.87 | 25.36 | 28.54 | 29.82 | 30.31 | 29.73 | 31.18 | — | — | — |
Based on: 10-K (filing date: 2021-02-25), 10-Q (filing date: 2020-10-30), 10-Q (filing date: 2020-07-31), 10-Q (filing date: 2020-05-01), 10-K (filing date: 2020-02-26), 10-Q (filing date: 2019-11-01), 10-Q (filing date: 2019-08-02), 10-Q (filing date: 2019-05-03), 10-K (filing date: 2019-02-27), 10-Q (filing date: 2018-11-02), 10-Q (filing date: 2018-08-03), 10-Q (filing date: 2018-05-04), 10-K (filing date: 2018-02-28), 10-Q (filing date: 2017-11-03), 10-Q (filing date: 2017-08-04), 10-Q (filing date: 2017-05-05), 10-K (filing date: 2017-02-28), 10-Q (filing date: 2016-11-04), 10-Q (filing date: 2016-08-05), 10-Q (filing date: 2016-05-06).
1 Q4 2020 Calculation
Net fixed asset turnover
= (RevenuesQ4 2020
+ RevenuesQ3 2020
+ RevenuesQ2 2020
+ RevenuesQ1 2020)
÷ Property, plant and equipment, net
= (10,550 + 8,521 + 6,917 + 6,230)
÷ 5,912 = 5.45
2 Click competitor name to see calculations.
Long-term activity ratio | Description | The company |
---|---|---|
Net fixed asset turnover | An activity ratio calculated as total revenue divided by net fixed assets. | Thermo Fisher Scientific Inc.’s net fixed asset turnover ratio improved from Q2 2020 to Q3 2020 but then slightly deteriorated from Q3 2020 to Q4 2020. |
Total Asset Turnover
Thermo Fisher Scientific Inc., total asset turnover calculation (quarterly data)
Dec 31, 2020 | Sep 26, 2020 | Jun 27, 2020 | Mar 28, 2020 | Dec 31, 2019 | Sep 28, 2019 | Jun 29, 2019 | Mar 30, 2019 | Dec 31, 2018 | Sep 29, 2018 | Jun 30, 2018 | Mar 31, 2018 | Dec 31, 2017 | Sep 30, 2017 | Jul 1, 2017 | Apr 1, 2017 | Dec 31, 2016 | Oct 1, 2016 | Jul 2, 2016 | Apr 2, 2016 | |||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Selected Financial Data (US$ in millions) | ||||||||||||||||||||||||||
Revenues | 10,550 | 8,521 | 6,917 | 6,230 | 6,829 | 6,272 | 6,316 | 6,125 | 6,507 | 5,920 | 6,078 | 5,853 | 6,047 | 5,116 | 4,990 | 4,765 | 4,953 | 4,491 | 4,535 | 4,295 | ||||||
Total assets | 69,052 | 64,061 | 61,593 | 58,688 | 58,381 | 56,729 | 57,970 | 55,596 | 56,232 | 55,078 | 55,403 | 56,580 | 56,669 | 55,985 | 46,514 | 46,214 | 45,908 | 48,011 | 42,253 | 42,953 | ||||||
Long-term Activity Ratio | ||||||||||||||||||||||||||
Total asset turnover1 | 0.47 | 0.44 | 0.43 | 0.44 | 0.44 | 0.44 | 0.43 | 0.44 | 0.43 | 0.43 | 0.42 | 0.39 | 0.37 | 0.35 | 0.41 | 0.41 | 0.40 | — | — | — | ||||||
Benchmarks | ||||||||||||||||||||||||||
Total Asset Turnover, Competitors2 | ||||||||||||||||||||||||||
Becton, Dickinson & Co. | 0.32 | 0.31 | 0.33 | 0.33 | 0.33 | 0.33 | 0.32 | 0.32 | 0.30 | 0.27 | 0.25 | 0.22 | 0.32 | 0.33 | 0.51 | 0.51 | 0.49 | 0.47 | 0.47 | 0.43 | ||||||
Boston Scientific Corp. | 0.32 | 0.33 | 0.33 | 0.36 | 0.35 | 0.39 | 0.41 | 0.42 | 0.47 | 0.47 | 0.48 | 0.48 | 0.48 | 0.47 | 0.47 | 0.48 | 0.46 | — | — | — | ||||||
Danaher Corp. | 0.29 | 0.28 | 0.27 | 0.26 | 0.29 | 0.30 | 0.35 | 0.38 | 0.42 | 0.41 | 0.40 | 0.40 | 0.39 | 0.39 | 0.38 | 0.38 | 0.37 | — | — | — | ||||||
Edwards Lifesciences Corp. | 0.61 | 0.64 | 0.67 | 0.74 | 0.67 | 0.70 | 0.71 | 0.70 | 0.70 | 0.61 | 0.62 | 0.59 | 0.60 | 0.60 | 0.63 | 0.66 | 0.66 | — | — | — | ||||||
Intuitive Surgical Inc. | 0.39 | 0.41 | 0.43 | 0.47 | 0.46 | 0.47 | 0.47 | 0.47 | 0.47 | 0.49 | 0.50 | 0.51 | 0.54 | 0.53 | 0.55 | 0.58 | 0.42 | — | — | — | ||||||
Medtronic PLC | 0.32 | 0.33 | 0.34 | 0.34 | 0.34 | 0.34 | 0.34 | 0.33 | 0.33 | 0.31 | 0.31 | 0.30 | 0.30 | 0.30 | 0.29 | 0.29 | 0.29 | 0.28 | 0.25 | 0.22 | ||||||
Stryker Corp. | 0.42 | 0.44 | 0.45 | 0.51 | 0.49 | 0.55 | 0.54 | 0.53 | 0.50 | 0.60 | 0.60 | 0.58 | 0.56 | 0.56 | 0.56 | 0.57 | 0.55 | — | — | — | ||||||
UnitedHealth Group Inc. | 1.30 | 1.31 | 1.28 | 1.29 | 1.38 | 1.37 | 1.40 | 1.43 | 1.48 | 1.45 | 1.37 | 1.33 | 1.44 | 1.39 | 1.39 | 1.37 | 1.50 | — | — | — |
Based on: 10-K (filing date: 2021-02-25), 10-Q (filing date: 2020-10-30), 10-Q (filing date: 2020-07-31), 10-Q (filing date: 2020-05-01), 10-K (filing date: 2020-02-26), 10-Q (filing date: 2019-11-01), 10-Q (filing date: 2019-08-02), 10-Q (filing date: 2019-05-03), 10-K (filing date: 2019-02-27), 10-Q (filing date: 2018-11-02), 10-Q (filing date: 2018-08-03), 10-Q (filing date: 2018-05-04), 10-K (filing date: 2018-02-28), 10-Q (filing date: 2017-11-03), 10-Q (filing date: 2017-08-04), 10-Q (filing date: 2017-05-05), 10-K (filing date: 2017-02-28), 10-Q (filing date: 2016-11-04), 10-Q (filing date: 2016-08-05), 10-Q (filing date: 2016-05-06).
1 Q4 2020 Calculation
Total asset turnover
= (RevenuesQ4 2020
+ RevenuesQ3 2020
+ RevenuesQ2 2020
+ RevenuesQ1 2020)
÷ Total assets
= (10,550 + 8,521 + 6,917 + 6,230)
÷ 69,052 = 0.47
2 Click competitor name to see calculations.
Long-term activity ratio | Description | The company |
---|---|---|
Total asset turnover | An activity ratio calculated as total revenue divided by total assets. | Thermo Fisher Scientific Inc.’s total asset turnover ratio improved from Q2 2020 to Q3 2020 and from Q3 2020 to Q4 2020. |
Equity Turnover
Thermo Fisher Scientific Inc., equity turnover calculation (quarterly data)
Dec 31, 2020 | Sep 26, 2020 | Jun 27, 2020 | Mar 28, 2020 | Dec 31, 2019 | Sep 28, 2019 | Jun 29, 2019 | Mar 30, 2019 | Dec 31, 2018 | Sep 29, 2018 | Jun 30, 2018 | Mar 31, 2018 | Dec 31, 2017 | Sep 30, 2017 | Jul 1, 2017 | Apr 1, 2017 | Dec 31, 2016 | Oct 1, 2016 | Jul 2, 2016 | Apr 2, 2016 | |||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Selected Financial Data (US$ in millions) | ||||||||||||||||||||||||||
Revenues | 10,550 | 8,521 | 6,917 | 6,230 | 6,829 | 6,272 | 6,316 | 6,125 | 6,507 | 5,920 | 6,078 | 5,853 | 6,047 | 5,116 | 4,990 | 4,765 | 4,953 | 4,491 | 4,535 | 4,295 | ||||||
Shareholders’ equity | 34,507 | 31,824 | 29,875 | 28,559 | 29,675 | 29,355 | 28,729 | 27,693 | 27,586 | 26,890 | 26,445 | 26,123 | 25,413 | 24,702 | 22,392 | 21,795 | 21,539 | 21,659 | 21,264 | 20,924 | ||||||
Long-term Activity Ratio | ||||||||||||||||||||||||||
Equity turnover1 | 0.93 | 0.90 | 0.88 | 0.90 | 0.86 | 0.86 | 0.87 | 0.89 | 0.88 | 0.89 | 0.87 | 0.84 | 0.82 | 0.80 | 0.86 | 0.86 | 0.85 | — | — | — | ||||||
Benchmarks | ||||||||||||||||||||||||||
Equity Turnover, Competitors2 | ||||||||||||||||||||||||||
Becton, Dickinson & Co. | 0.72 | 0.70 | 0.83 | 0.82 | 0.82 | 0.80 | 0.80 | 0.80 | 0.76 | 0.69 | 0.64 | 0.58 | 0.93 | 0.97 | 1.55 | 1.64 | 1.64 | 1.53 | 1.60 | 1.55 | ||||||
Boston Scientific Corp. | 0.65 | 0.65 | 0.65 | 0.78 | 0.77 | 1.07 | 1.07 | 1.08 | 1.13 | 1.17 | 1.23 | 1.32 | 1.29 | 1.16 | 1.20 | 1.22 | 1.25 | — | — | — | ||||||
Danaher Corp. | 0.56 | 0.54 | 0.52 | 0.58 | 0.59 | 0.57 | 0.59 | 0.62 | 0.71 | 0.71 | 0.71 | 0.69 | 0.70 | 0.70 | 0.71 | 0.72 | 0.73 | — | — | — | ||||||
Edwards Lifesciences Corp. | 0.96 | 1.04 | 1.13 | 1.15 | 1.05 | 1.09 | 1.13 | 1.11 | 1.19 | 1.08 | 1.12 | 1.06 | 1.16 | 1.05 | 1.10 | 1.15 | 1.13 | — | — | — | ||||||
Intuitive Surgical Inc. | 0.45 | 0.47 | 0.50 | 0.54 | 0.54 | 0.55 | 0.56 | 0.55 | 0.56 | 0.57 | 0.59 | 0.60 | 0.66 | 0.60 | 0.63 | 0.67 | 0.47 | — | — | — | ||||||
Medtronic PLC | 0.57 | 0.60 | 0.61 | 0.61 | 0.61 | 0.61 | 0.61 | 0.60 | 0.59 | 0.59 | 0.58 | 0.59 | 0.59 | 0.59 | 0.58 | 0.57 | 0.55 | 0.56 | 0.50 | 0.44 | ||||||
Stryker Corp. | 1.10 | 1.10 | 1.10 | 1.14 | 1.16 | 1.18 | 1.19 | 1.19 | 1.16 | 1.35 | 1.38 | 1.38 | 1.25 | 1.16 | 1.19 | 1.21 | 1.19 | — | — | — | ||||||
UnitedHealth Group Inc. | 3.90 | 3.85 | 3.87 | 4.29 | 4.17 | 4.33 | 4.41 | 4.44 | 4.35 | 4.37 | 4.40 | 4.34 | 4.19 | 4.32 | 4.44 | 4.49 | 4.81 | — | — | — |
Based on: 10-K (filing date: 2021-02-25), 10-Q (filing date: 2020-10-30), 10-Q (filing date: 2020-07-31), 10-Q (filing date: 2020-05-01), 10-K (filing date: 2020-02-26), 10-Q (filing date: 2019-11-01), 10-Q (filing date: 2019-08-02), 10-Q (filing date: 2019-05-03), 10-K (filing date: 2019-02-27), 10-Q (filing date: 2018-11-02), 10-Q (filing date: 2018-08-03), 10-Q (filing date: 2018-05-04), 10-K (filing date: 2018-02-28), 10-Q (filing date: 2017-11-03), 10-Q (filing date: 2017-08-04), 10-Q (filing date: 2017-05-05), 10-K (filing date: 2017-02-28), 10-Q (filing date: 2016-11-04), 10-Q (filing date: 2016-08-05), 10-Q (filing date: 2016-05-06).
1 Q4 2020 Calculation
Equity turnover
= (RevenuesQ4 2020
+ RevenuesQ3 2020
+ RevenuesQ2 2020
+ RevenuesQ1 2020)
÷ Shareholders’ equity
= (10,550 + 8,521 + 6,917 + 6,230)
÷ 34,507 = 0.93
2 Click competitor name to see calculations.
Long-term activity ratio | Description | The company |
---|---|---|
Equity turnover | An activity ratio calculated as total revenue divided by shareholders’ equity. | Thermo Fisher Scientific Inc.’s equity turnover ratio improved from Q2 2020 to Q3 2020 and from Q3 2020 to Q4 2020. |